PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32011683-0	2020	Genetic influence of ABCG2, UGT1A1 and NR1I2 on dolutegravir plasma pharmacokinetics.	dolutegravir	48-60	nuclear receptor subfamily 1 group I member 2	Homo sapiens	39-44	
32011683-2	2020	We sought to ascertain the contributory effect of SNPs in four key genes linked to dolutegravir disposition (UGT1A1, ABCG2, CYP3A and NR1I2) on plasma dolutegravir pharmacokinetics.	dolutegravir	83-95	nuclear receptor subfamily 1 group I member 2	Homo sapiens	134-139	
32011683-2	2020	We sought to ascertain the contributory effect of SNPs in four key genes linked to dolutegravir disposition (UGT1A1, ABCG2, CYP3A and NR1I2) on plasma dolutegravir pharmacokinetics.	dolutegravir	151-163	nuclear receptor subfamily 1 group I member 2	Homo sapiens	134-139	
32011683-8	2020	CONCLUSIONS: This study showed a pharmacogenetic association between dolutegravir pharmacokinetics and variants in the ABCG2, UGT1A1 and NR1I2 genes, particularly when combined.	dolutegravir	69-81	nuclear receptor subfamily 1 group I member 2	Homo sapiens	137-142